The End of Chiron
Novartis Corporation was the result of a merger between Sandoz Laboratories and Ciba-Geigy in 1994 and owned slightly less than half of Chiron as part of a Federal Trade Commission order. Several of Sandoz’s subsidiaries were sold off for reasons of anti monopoly legislation. In 2005, Novartis made an offer to buy Chiron. Initially this offer was rebuffed, but after the bid was substantially enhanced, Chiron was sold, and became part of Novartis in April, 2006.
Read more about this topic: Chiron Corporation
Famous quotes containing the words the end:
“‘Tis said that courage is common, but the immense esteem in which it is held proves it to be rare. Animal resistance, the instinct of the male animal when cornered, is no doubt common; but the pure article, courage with eyes, courage with conduct, self-possession at the cannon’s mouth, cheerfulness in lonely adherence to the right, is the endowment of elevated characters.”
—Ralph Waldo Emerson (1803–1882)